JOHN D ROGERS
Engineers in Delaware
License number
Pennsylvania PE010730E
Category
Engineers
Type
Professional Engineer
Address
Address
2
Delaware
Rosemont, PA 19010
Rosemont, PA 19010
Professional information
Aryl Sulfonic Acids And Derivatives As Fsh Antagonists
US Patent:
6355633, Mar 12, 2002
Filed:
Mar 24, 2000
Appl. No.:
09/535492
Inventors:
Jay E. Wrobel - Lawrenceville NJ
John F. Rogers - Bryn Mawr PA
Daniel M. Green - Ambler PA
Wenling Kao - Paoli PA
James W. Jetter - Norristown PA
John F. Rogers - Bryn Mawr PA
Daniel M. Green - Ambler PA
Wenling Kao - Paoli PA
James W. Jetter - Norristown PA
Assignee:
American Home Products Corporation - Madison NJ
International Classification:
A61K 31167
US Classification:
51421201, 5142382, 51425211, 5142275, 514445, 514709, 514408, 514316
Abstract:
This invention provides compounds of formula I having the structure wherein R , Ar, Arâ², and Q are as defined in the specification, or a pharmaceutically acceptable salt thereof, which are useful as contraceptive agents.
Aryl Sulfonic Acids And Derivatives As Fsh Antagonists
US Patent:
2002011, Aug 15, 2002
Filed:
Jan 10, 2002
Appl. No.:
10/043442
Inventors:
Jay Wrobel - Lawrenceville NJ, US
John Rogers - Bryn Mawr PA, US
Daniel Green - Ambler PA, US
Wenling Kao - Paoli PA, US
James Jetter - Norristown PA, US
John Rogers - Bryn Mawr PA, US
Daniel Green - Ambler PA, US
Wenling Kao - Paoli PA, US
James Jetter - Norristown PA, US
Assignee:
American Home Products Corporation - Madison NJ
International Classification:
A61K031/444, A61K031/4439, A61K031/4025, A61K031/185, A61K031/18, C 07D 4 3/02, C 07D 4 1/02
US Classification:
514/332000, 514/343000, 514/422000, 514/553000, 514/603000, 546/255000, 546/276400, 548/518000, 562/047000
Abstract:
This invention provides compounds of formula I having the structure
wherein Q is hydrogen or —SOR; X is a bond, O, S(O), —CH CH—, —CHCH—, —C≡C—, or —CHS(O)CH—; Ris OH, NH, Cto Calkoxy, Cto Cperfluoroalkoxy;
Rand Rare each, independently, hydrogen, OR, —S(O)R, —NHR, —N(R), or —CHSOCH; Rand Rare each, independently, hydrogen, —NO, —NH, —SOR, or —CHR; Ris hydrogen, Cto Calkyl, Cto Calkenyl, —CHCHZ, —CHCOR, —CHCH CHCOR
Yand Yare each, independently, N, or CH; Yand Yare each independently, O, S, or NR; Ris —OR, —NHR, —N(R), or —NHCHCHOR; Z is —OR, —OCHCHOR, —N(R), or
Ris hydrogen, or Cto Calkyl; Ris Cto Calkyl, Cto Calkenyl, OH, NHR, N(R), CHCOR, —CHCH CHCOR, or
Ris Cto Calkyl, Cto Calkenyl, phenyl, —CHCHOCH, or
Ris —OR, NHR, —N(R), or —NHCHCHOR; Ris hydrogen, or Cto Calkyl; Ris hydrogen, or Cto Calkyl; W is a bond, CH, CHCH, O, S(O), NCHO, NCOCH, or NR; m is 0-2; n is 0-2; q is 0-2, with the proviso that Rand Rare not both hydrogen; or pharmaceutically acceptable salt thereof, which are useful as contraceptive agents.
Aryl Sulfonic Acids As Fsh Antagonists
US Patent:
6200963, Mar 13, 2001
Filed:
Mar 24, 2000
Appl. No.:
9/537472
Inventors:
Jay E. Wrobel - Lawrenceville NJ
John F. Rogers - Bryn Mawr PA
Wenling Kao - Chester PA
John F. Rogers - Bryn Mawr PA
Wenling Kao - Chester PA
Assignee:
American Home Products Corporation - Madison NJ
International Classification:
A61K 31655, C07C30935, C07D25122
US Classification:
514150
Abstract:
##STR1##
wherein:
R. sup. 1 is a moiety selected from: ##STR2##
R. sup. 2 is CH. sub. 2 CH. sub. 2 CONH. sub. 2 or CH. sub. 2 CH. sub. 2 OH;
R. sup. 3 and R. sup. 4 are independent substituents selected from the group including H, --N(CH. sub. 3). sub. 2, or --OCH. sub. 3 ;
or pharmaceutically acceptable salts thereof.
Imidazo[4,5-B]Pyridine Antagonists Of Gonadotropin Releasing Hormone Receptor
US Patent:
2006018, Aug 24, 2006
Filed:
Feb 15, 2006
Appl. No.:
11/355298
Inventors:
Jeffrey Pelletier - Lafayette Hill PA, US
John Rogers - Bryn Mawr PA, US
John Rogers - Bryn Mawr PA, US
Assignee:
WYETH - Madison NJ
International Classification:
A61K 31/519, A61K 31/506, A61K 31/513, A61K 31/498, A61K 31/496, C07D 487/04, C07D 471/02
US Classification:
514248000, 544237000, 544281000, 544295000, 544330000, 544333000, 544362000, 514249000, 514252160, 514253040
Abstract:
The present invention relates to Gonadotropin Releasing Hormone (GnRH, also known as Luteinizing Hormone Releasing Hormone) receptor antagonists.
7-Substituted Imidazo[4,5-C]Pyridine Antagonists Of Gonadotropin Releasing Hormone Receptor
US Patent:
2006018, Aug 24, 2006
Filed:
Feb 15, 2006
Appl. No.:
11/354793
Inventors:
Jeffrey Pelletier - Lafayette Hill PA, US
John Rogers - Bryn Mawr PA, US
John Rogers - Bryn Mawr PA, US
Assignee:
WYETH - Madison NJ
International Classification:
A61K 31/519, A61K 31/513, A61K 31/502, A61K 31/498, A61K 31/496, C07D 487/04, C07D 471/02
US Classification:
514248000, 544235000, 544280000, 544295000, 544330000, 544333000, 544362000, 514249000, 514252160, 514252180, 514253040
Abstract:
The present invention relates to Gonadotropin Releasing Hormone (GnRH, also known as Luteinizing Hormone Releasing Hormone) receptor antagonists.
Gonadotropin Releasing Hormone Receptor Antagonists
US Patent:
2006001, Jan 26, 2006
Filed:
Jun 16, 2005
Appl. No.:
11/154795
Inventors:
Lloyd Garrick - Arvada CO, US
Daniel Green - Ambler PA, US
Diane Hauze - St. Davids PA, US
Kenneth Kees - Glenmoore PA, US
Joseph Lundquist - Collegeville PA, US
Charles Mann - Philadelphia PA, US
John Mehlmann - King of Prussia PA, US
Jeffrey Pelletier - Lafayette Hill PA, US
John Rogers - Bryn Mawr PA, US
Jay Wrobel - Lawrenceville NJ, US
Daniel Green - Ambler PA, US
Diane Hauze - St. Davids PA, US
Kenneth Kees - Glenmoore PA, US
Joseph Lundquist - Collegeville PA, US
Charles Mann - Philadelphia PA, US
John Mehlmann - King of Prussia PA, US
Jeffrey Pelletier - Lafayette Hill PA, US
John Rogers - Bryn Mawr PA, US
Jay Wrobel - Lawrenceville NJ, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 31/496, C07D 43/02
US Classification:
514254060, 544370000
Abstract:
The present invention relates to Gonadotropin Releasing Hormone (“GnRH”) (also known as Leutinizing Hormone Releasing Hormone) receptor antagonists.
Gonadotropin Releasing Hormone Receptor Antagonists
US Patent:
2006011, May 25, 2006
Filed:
Nov 23, 2005
Appl. No.:
11/286081
Inventors:
Lloyd Garrick - Arvada CO, US
Daniel Green - Ambler PA, US
James Jetter - Norristown PA, US
Wenling Kao - Fremont CA, US
Kenneth Kees - Glenmoore PA, US
Jeffrey Pelletier - Lafayette Hill PA, US
John Rogers - Bryn Mawr PA, US
Daniel Green - Ambler PA, US
James Jetter - Norristown PA, US
Wenling Kao - Fremont CA, US
Kenneth Kees - Glenmoore PA, US
Jeffrey Pelletier - Lafayette Hill PA, US
John Rogers - Bryn Mawr PA, US
Assignee:
WYETH - Madison NJ
International Classification:
A61K 31/506, A61K 31/496, A61K 31/501, A61K 31/498, C07D 403/14, C07D 413/14, C07D 417/14
US Classification:
514248000, 514254090, 514249000, 514252190, 514252110, 514253060, 514254050, 514254060, 514253050, 544236000, 544295000, 544333000, 544357000, 544360000, 544363000, 544368000, 544373000, 514254020
Abstract:
The present invention relates to Gonadotropin Releasing Hormone (“GnRH”) (also known as Luteinizing Hormone Releasing Hormone) receptor antagonists.